Syndax Pharmaceuticals Inc (SNDX)
Sales/Maturities of Investments
$69.00M
Quarterly · Period ending: · USD
SNDX Sales/Maturities of Investments
Latest reported$69.00Mperiod ending
Latest reported$69.00Mperiod ending
SNDX Quarterly Sales/Maturities of Investments ($0.00 → $69.00M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
SNDX sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 69,000,000 | |
| 77,777,000 | |
| 144,750,000 | |
| 103,000,000 | |
| 133,600,000 | |
| 104,680,000 | |
| 107,341,000 | |
| 100,200,000 | |
| 61,750,000 | |
| 67,986,000 | |
| 113,000,000 | |
| 122,800,000 | |
| 154,915,000 | |
| 81,500,000 | |
| 113,250,000 | |
| 72,817,000 | |
| 72,418,000 | |
| 50,448,000 | |
| 45,400,000 | |
| 89,575,000 | |
| 81,500,000 | |
| 37,500,000 | |
| 64,447,000 | |
| 38,500,000 | |
| 17,575,000 | |
| 15,885,000 | |
| 41,722,000 | |
| 21,362,000 | |
| 20,335,000 | |
| 33,380,000 | |
| 34,679,000 | |
| 29,500,000 | |
| 41,750,000 | |
| 24,500,000 | |
| 40,843,000 | |
| 31,985,000 | |
| 37,352,000 | |
| 25,095,000 | |
| 47,895,000 | |
| 30,025,000 | |
| 30,520,000 | |
| 31,857,000 | |
| 15,877,000 | |
| 19,284,000 | |
| 3,265,000 | |
| 2,080,000 | |
| 0 | |
| 0 | |
| 2,536,000 | |
| 2,750,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |